Overview
Lixin Cheng practices practicing medicine in Ningbo, China.
Their clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Hashimoto Thyroiditis, and Thyroidectomy.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lixin Cheng
Is Lixin Cheng a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Lixin Cheng is classified as an Experienced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lixin Cheng participate in research or clinical trials?
Yes. Lixin Cheng has published 11 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Lixin Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hashimoto ThyroiditisCheng isExperienced. Learn about Hashimoto Thyroiditis.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- ThyroidectomyCheng isExperienced. Learn about Thyroidectomy.